Antimicrobial Agents Practice Questions

Q: A 75-year-old male develops a cough producing blood-tinged sputum and a fever of 104°F. A sputum smear reveals Gram-positive cocci in clusters, and a chest x-ray shows increased density in the right upper lobe. Which of the following penicillins is most likely to be ineffective against this patient's likely pathogen?

Ticarcillin. **Explanation:** **1. Analysis of the Clinical Scenario:** The patient presents with symptoms of pneumonia (fever, cough, blood-tinged sputum). The key diagnostic clue is the sputum smear showing **Gram-positive cocci in clusters**, which is pathognomonic for ***Staphylococcus aureus***. Most community and hospital strains of *S. aureus* produce **penicillinase** (a type of $\beta$-lactamase), making them resistant to standard penicillins like Penicillin G and Aminopenicillins. **2. Why Ticarcillin is the Correct Answer:** **Ticarcillin** is a carboxypenicillin categorized as an **Antipseudomonal penicillin**. While it has excellent activity against Gram-negative rods (like *Pseudomonas aeruginosa*), it is **susceptible to degradation by staphylococcal penicillinase**. Therefore, it is ineffective against penicillinase-producing *S. aureus* unless combined with a $\beta$-lactamase inhibitor (e.g., Clavulanic acid). **3. Why the Other Options are Incorrect:** * **Oxacillin, Cloxacillin, and Nafcillin** belong to the class of **Antistaphylococcal penicillins**. These drugs possess bulky side chains that sterically hinder the action of staphylococcal $\beta$-lactamase. They are the drugs of choice for Methicillin-Sensitive *Staphylococcus aureus* (MSSA). **High-Yield Clinical Pearls for NEET-PG:** * **DOC for MSSA:** Nafcillin (IV) or Cloxacillin (Oral). * **MRSA Mechanism:** Resistance is due to an altered target site (**PBP-2a**), encoded by the ***mecA* gene**, not $\beta$-lactamase production. Therefore, even antistaphylococcal penicillins fail against MRSA. * **Antipseudomonal Penicillins:** Include Carboxypenicillins (Ticarcillin, Carbenicillin) and Ureidopenicillins (Piperacillin). Remember: "Piperacillin is the most potent among these."

Q: Which antimalarial agent(s) should be avoided in pregnancy?

Primaquine. The correct answer is **Primaquine**. **Why Primaquine is avoided:** Primaquine is strictly contraindicated throughout pregnancy [1]. The primary concern is that the drug can cross the placenta and reach the fetus. If the fetus is **Glucose-6-Phosphate Dehydrogenase (G6PD) deficient**, Primaquine can induce severe **fetal hemolysis**, leading to intrauterine anemia and potential fetal demise [1]. Since the G6PD status of a fetus cannot be safely determined in utero, the drug is withheld until after delivery. **Analysis of other options:** * **Chloroquine:** It is considered the drug of choice for sensitive *P. falciparum* and *P. vivax* during all trimesters of pregnancy [1]. It is safe and non-teratogenic. * **Quinine:** It is the mainstay of treatment for severe malaria or chloroquine-resistant malaria in the first trimester. While high doses can be oxytocic, therapeutic doses are safe. * **Anti-folates (e.g., Sulfadoxine-Pyrimethamine):** These are used for Intermittent Preventive Treatment (IPTp) in the second and third trimesters. **Tetracyclines** (Doxycycline) are indeed avoided in pregnancy due to effects on fetal bones and teeth [1], but since the question asks for the most definitive "antimalarial agent" (singular/primary focus) and Primaquine carries the specific risk of fetal hemolysis, Primaquine remains the most classic contraindication in this context. **NEET-PG High-Yield Pearls:** * **Tafenoquine**, like Primaquine, is also contraindicated in pregnancy due to G6PD-related hemolysis risks. * **Artemisinin-based Combination Therapy (ACT):** Now recommended by the WHO as first-line treatment for uncomplicated malaria in **all trimesters**, including the first. * **Radical Cure:** For *P. vivax* in pregnancy, treat the acute attack with Chloroquine and defer Primaquine (radical cure for hypnozoites) until after the mother has finished breastfeeding [1].

Q: Which of the following antibiotics has the maximum auditory toxicity?

Amikacin. ### Explanation Aminoglycosides are notorious for their dose-dependent and duration-dependent **ototoxicity**, which can manifest as either **vestibular damage** (balance issues) or **cochlear damage** (hearing loss). This toxicity occurs due to the accumulation of the drug in the perilymph and endolymph, leading to the destruction of sensory hair cells. **Why Amikacin is the correct answer:** While all aminoglycosides can cause both types of damage, they exhibit a preference for one over the other. **Amikacin** and **Kanamycin** are the most potent **cochleotoxic** agents in this class. Among the options provided, Amikacin is clinically recognized for having the **maximum auditory toxicity**, often leading to irreversible high-frequency hearing loss. **Analysis of Incorrect Options:** * **Streptomycin:** Primarily **vestibulotoxic**. It is more likely to cause vertigo and nystagmus than hearing loss. * **Kanamycin:** Highly cochleotoxic, but in modern clinical practice and standardized competitive exams, Amikacin is cited as having the highest potential for auditory damage. * **Tobramycin:** Similar to Gentamicin, it affects both systems but is predominantly **vestibulotoxic**. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Ototoxicity:** * **Cochleotoxic (Hearing):** **A**mikacin, **K**anamycin, **N**eomycin (Mnemonic: **AKN** - "A"uditory). * **Vestibulotoxic (Balance):** **S**treptomycin, **G**entamicin (Mnemonic: **SG** - "S"haking). * **Nephrotoxicity:** **Neomycin** is the most nephrotoxic (hence used only topically/orally), while **Streptomycin** is the least. * **Neuromuscular Blockade:** Aminoglycosides can worsen Myasthenia Gravis; **Neomycin** is the most potent blocker, while **Tobramycin** is the least. * **Monitoring:** Ototoxicity is often irreversible; therefore, baseline and periodic audiometry are recommended during prolonged therapy.

Q: Resistance to acyclovir is most commonly due to mutation in the viral gene that encodes a protein that:

Phosphorylates acyclovir. ### Explanation **Correct Option: B. Phosphorylates acyclovir** Acyclovir is a **nucleoside analog** that acts as a prodrug. To become active, it must undergo three phosphorylation steps. The first and most critical step is the conversion of acyclovir to acyclovir monophosphate, which is mediated by the viral enzyme **Thymidine Kinase (TK)**. Host cell enzymes then complete the conversion to acyclovir triphosphate, which inhibits viral DNA polymerase. The most common mechanism of resistance in Herpes Simplex Virus (HSV) and Varicella-Zoster Virus (VZV) is a **mutation in the viral gene encoding Thymidine Kinase**, resulting in a "TK-deficient" or "TK-altered" strain. Without this initial phosphorylation, the drug cannot be activated. **Analysis of Incorrect Options:** * **A. Converts viral RNA into DNA:** This describes Reverse Transcriptase (found in HIV). Acyclovir targets DNA viruses (HSV/VZV) and does not involve reverse transcription. * **C & D. Transport mechanisms:** Resistance to acyclovir is biochemical (enzymatic), not related to cellular influx or efflux pumps. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism of Action:** Acyclovir triphosphate acts as a **chain terminator** because it lacks a 3' hydroxyl group, preventing further DNA elongation. * **Selectivity:** Acyclovir is highly selective because its initial phosphorylation occurs 100-1000 times faster in virus-infected cells than in uninfected cells. * **Cross-Resistance:** TK-deficient strains are also resistant to Valacyclovir and Famciclovir. * **Alternative for Resistance:** In cases of acyclovir resistance (common in immunocompromised patients), **Foscarnet** or **Cidofovir** are used because they do not require phosphorylation by viral Thymidine Kinase to be active.

Q: What is the drug of choice for late East African Trypanosomiasis?

Melarsoprol. **Explanation:** The treatment of African Trypanosomiasis (Sleeping Sickness) is determined by the species (*T. brucei gambiense* vs. *rhodesiense*) and the stage of the disease (Early/Hemic-lymphatic vs. Late/Meningoencephalitic). **Why Melarsoprol is correct:** **Melarsoprol** is the drug of choice for **late-stage East African Trypanosomiasis** (*T. b. rhodesiense*). In the late stage, the parasite crosses the blood-brain barrier (BBB). Melarsoprol is an organic arsenical compound that is highly lipid-soluble, allowing it to achieve therapeutic concentrations in the CNS to kill the parasites. **Analysis of Incorrect Options:** * **Pentamidine (A):** Used for the **early stage** of West African Trypanosomiasis (*T. b. gambiense*). It does not cross the BBB. * **Suramin (B):** The drug of choice for the **early stage** of East African Trypanosomiasis (*T. b. rhodesiense*). Like pentamidine, it lacks CNS penetration. * **Nifurtimox (D):** Primarily used for **Chagas disease** (American Trypanosomiasis). It is also used in combination with Eflornithine (NECT) for late-stage West African Trypanosomiasis, but not as monotherapy for the East African variety. **High-Yield Clinical Pearls for NEET-PG:** 1. **Toxicity:** Melarsoprol is highly toxic; the most feared side effect is **reactive encephalopathy** (seen in 5-10% of patients), which can be fatal. 2. **West vs. East:** Remember **"EAR"** for East African = **S**uramin (Early) and **M**elarsoprol (Late). 3. **Eflornithine:** Known as the "resurrection drug," it is the drug of choice for late-stage West African Trypanosomiasis but is **ineffective** against the East African species.

Q: What is the daily dose of isoniazid in the treatment of tuberculosis?

5 mg/kg body weight. **Explanation:** The standard daily dose of **Isoniazid (INH)** for the treatment of tuberculosis in adults is **5 mg/kg body weight** (maximum 300 mg per day). This dosage is optimized to maintain therapeutic efficacy while minimizing the risk of dose-dependent toxicity. **Why Option A is correct:** Isoniazid is a bactericidal drug that inhibits the synthesis of mycolic acids, essential components of the mycobacterial cell wall. At a dose of 5 mg/kg, it achieves plasma concentrations significantly higher than the Minimum Inhibitory Concentration (MIC) for *M. tuberculosis*, effectively killing rapidly dividing intra- and extracellular bacilli. **Why other options are incorrect:** * **Option B (10 mg/kg):** This is the standard daily dose for **Rifampicin** (up to 600 mg) and is also the recommended dose for Isoniazid in **pediatric patients** (10–15 mg/kg) due to their faster metabolism. * **Options C & D (15-20 mg/kg):** These doses are excessively high for daily administration in adults and would significantly increase the risk of hepatotoxicity and peripheral neuropathy. However, 15 mg/kg is sometimes used in intermittent (thrice-weekly) supervised regimens. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism of Action:** Inhibits *inhA* and *kasA* enzymes involved in mycolic acid synthesis; it is a **prodrug** activated by the mycobacterial **KatG** enzyme. * **Adverse Effects:** 1. **Peripheral Neuropathy:** Caused by interference with Pyridoxine (Vitamin B6) metabolism. Always co-prescribe **10–50 mg/day of Vitamin B6**. 2. **Hepatotoxicity:** The most common serious side effect; risk increases with age and alcohol use. * **Metabolism:** Occurs via **Acetylation** (Genetic polymorphism: Fast vs. Slow acetylators). Slow acetylators are more prone to neuropathy. * **Drug of Choice:** For Latent TB infection (Chemoprophylaxis).

Q: What is the drug of choice for actinomycosis?

Penicillin. **Explanation:** **Actinomycosis** is a chronic, granulomatous infection caused by *Actinomyces israelii*, a Gram-positive, anaerobic, non-acid-fast branching filamentous bacterium. **1. Why Penicillin is the Correct Answer:** **Penicillin G** (intravenous) followed by **Penicillin V** (oral) is the definitive **drug of choice**. *Actinomyces* species are exquisitely sensitive to beta-lactams. Because the infection is characterized by dense fibrosis and "sulfur granules" (microcolonies) which limit drug penetration, high-dose, prolonged therapy (6–12 months) is required to prevent relapse. **2. Analysis of Incorrect Options:** * **Sulfonamides (B):** While historically used, they are significantly less effective than Penicillin and are not considered first-line. They are primarily used for *Nocardia* (which is acid-fast), often leading to confusion between the two. * **Tetracycline/Doxycycline (C):** These are considered **second-line** agents or the drug of choice only in patients with a **Penicillin allergy**. * **Azithromycin (D):** Macrolides have some activity but are not standard therapy and lack the robust clinical evidence supporting Penicillin or Tetracyclines for this specific infection. **3. High-Yield Clinical Pearls for NEET-PG:** * **The "Lumpy Jaw":** The most common presentation is cervicofacial actinomycosis, often following dental procedures or poor oral hygiene. * **Sulfur Granules:** A hallmark diagnostic finding in abscess pus (yellowish specks), though they do not actually contain sulfur. * **Differential Diagnosis:** Always distinguish from *Nocardia*. * *Actinomyces*: Anaerobic, Non-acid-fast, Rx: **Penicillin**. * *Nocardia*: Aerobic, Weakly acid-fast, Rx: **Cotrimoxazole**. * **IUD Association:** Pelvic actinomycosis is strongly associated with the long-term use of intrauterine contraceptive devices.

Q: What is the antibiotic of choice in patients with penicillin sensitivity?

Erythromycin. The correct answer is **Erythromycin**. **Why Erythromycin is the correct choice:** Erythromycin, a macrolide antibiotic, is classically considered the first-line alternative for patients with a documented **Type-I hypersensitivity (allergy) to Penicillin** [1]. This is because Erythromycin shares a similar antimicrobial spectrum with Penicillin G (targeting primarily Gram-positive cocci and bacilli), but it is chemically unrelated to beta-lactams. Therefore, there is no cross-reactivity, making it safe for penicillin-sensitive individuals in treating infections like streptococcal pharyngitis [2], diphtheria [3], and syphilis. **Analysis of incorrect options:** * **Streptomycin:** This is an aminoglycoside primarily used for tuberculosis and certain Gram-negative infections. It does not cover the typical Gram-positive spectrum of penicillin and carries risks of ototoxicity and nephrotoxicity. * **Tetracycline:** While broad-spectrum, it is bacteriostatic and has a different clinical profile. It is not the preferred substitute for routine penicillin-indicated infections due to widespread resistance and side effects (e.g., effects on teeth and bones). * **Chloramphenicol:** Though broad-spectrum, its use is severely restricted due to the risk of life-threatening bone marrow suppression (Aplastic Anemia) and Gray Baby Syndrome. It is never a first-line alternative for simple penicillin sensitivity. **NEET-PG High-Yield Pearls:** * **Cross-Reactivity:** Patients with penicillin allergy have a **5-10% risk** of cross-reactivity with first-generation Cephalosporins. However, Macrolides (Erythromycin, Azithromycin) have **zero** cross-reactivity. * **Drug of Choice (DOC):** Erythromycin is the DOC for *Legionella*, *Mycoplasma pneumoniae*, and *Diphtheria* (carriers and cases). * **Side Effect:** Erythromycin is a motilin agonist; it can cause epigastric pain and is sometimes used off-label for gastroparesis.

Q: What is the drug of choice for prophylaxis of meningococcal meningitis in a pregnant female after contact with a case?

Ceftriaxone. **Explanation:** The goal of post-exposure prophylaxis (PEP) for meningococcal meningitis (*Neisseria meningitidis*) is to eradicate nasopharyngeal carriage in close contacts to prevent invasive disease and further transmission. **Why Ceftriaxone is the Correct Choice:** In the general population, **Rifampin** (or Ciprofloxacin) is typically the drug of choice. However, in **pregnant females**, Rifampin is avoided due to potential teratogenicity (though evidence is limited, safer alternatives exist). **Ceftriaxone (250 mg IM single dose)** is the drug of choice for pregnant women because it is highly effective at eradicating the carrier state and has an excellent safety profile (Category B) during pregnancy. **Analysis of Incorrect Options:** * **A. Ciprofloxacin:** While a common single-dose oral option for adults, it is generally avoided in pregnancy due to concerns regarding fetal cartilage damage (arthropathy). * **C. Cefalexin:** This is a first-generation cephalosporin. It does not achieve adequate concentrations in the nasopharyngeal mucosa or cross the blood-brain barrier effectively enough to be used for meningococcal prophylaxis. * **D. Rifabutin:** While related to Rifampin, it is primarily used for *Mycobacterium avium* complex (MAC) prophylaxis in HIV patients and is not the standard of care for meningococcal PEP. **High-Yield Clinical Pearls for NEET-PG:** * **Standard DOC for PEP:** Rifampin (600 mg BID for 2 days). * **Alternative for Adults:** Ciprofloxacin (500 mg single oral dose). * **DOC for Pregnancy/Children:** Ceftriaxone (250 mg IM single dose). * **Close Contacts Defined:** Household members, daycare center contacts, or anyone directly exposed to the patient's oral secretions (e.g., kissing, intubation) within 7 days before symptom onset.

Q: What is the recommended daily dose of Isoniazid for children?

10-20 mg/kg. The correct answer is **B. 10-20 mg/kg**. ### **Explanation** Isoniazid (INH) is a cornerstone of Antitubercular Therapy (ATT). In pediatric patients, the metabolic rate of drugs is generally higher than in adults. According to the **WHO** and the **National Tuberculosis Elimination Program (NTEP)** guidelines, the recommended daily dose of Isoniazid for children is **10-15 mg/kg** (with a range extending up to **20 mg/kg** in some clinical scenarios). This higher weight-based dosage compared to adults is necessary to achieve therapeutic plasma concentrations, as children are often "rapid acetylators." ### **Analysis of Options** * **Option A (5 mg/kg):** This is the standard daily dose for **adults**, not children. Using this dose in children would lead to sub-therapeutic levels and potential treatment failure. * **Option C (15-25 mg/kg):** This range is typically associated with **Ethambutol** (15-25 mg/kg) or Pyrazinamide (30-35 mg/kg) in certain pediatric protocols. * **Option D (20-40 mg/kg):** This is an excessively high dose for Isoniazid and would significantly increase the risk of hepatotoxicity and neurotoxicity. ### **High-Yield Clinical Pearls for NEET-PG** * **Mechanism of Action:** Inhibits the synthesis of **mycolic acids** by targeting the *InhA* enzyme. * **Metabolism:** Metabolized via **Acetylation** (Phase II reaction). Genetic polymorphism leads to "Fast" and "Slow" acetylators. * **Side Effects:** Peripheral neuropathy (due to **Vitamin B6/Pyridoxine deficiency**) and Hepatotoxicity (most common). * **Prophylaxis:** Isoniazid is the drug of choice for Chemoprophylaxis in household contacts of TB patients (dose: 10 mg/kg for children). * **Supplementation:** Always co-prescribe **Pyridoxine (10-25 mg/day)** in children to prevent peripheral neuropathy.

Question 1

A 75-year-old male develops a cough producing blood-tinged sputum and a fever of 104°F. A sputum smear reveals Gram-positive cocci in clusters, and a chest x-ray shows increased density in the right upper lobe. Which of the following penicillins is most likely to be ineffective against this patient's likely pathogen?

Accepted Answer

Ticarcillin

Answer

Oxacillin

Answer

Cloxacillin

Answer

Nafcillin

Question 2

Which antimalarial agent(s) should be avoided in pregnancy?

Accepted Answer

Primaquine

Answer

Chloroquine

Answer

Quinine

Answer

Anti-folates and Tetracyclines

Question 3

Which of the following antibiotics has the maximum auditory toxicity?

Accepted Answer

Amikacin

Answer

Streptomycin

Answer

Kanamycin

Answer

Tobramycin

Question 4

Resistance to acyclovir is most commonly due to mutation in the viral gene that encodes a protein that:

Accepted Answer

Phosphorylates acyclovir

Answer

Converts viral RNA into DNA

Answer

Transports acyclovir into the cell

Answer

Transports acyclovir out of the cell

Question 5

What is the drug of choice for late East African Trypanosomiasis?

Accepted Answer

Melarsoprol

Answer

Pentamidine

Answer

Suramine

Answer

Nifurtimox

Question 6

What is the daily dose of isoniazid in the treatment of tuberculosis?

Accepted Answer

5 mg/kg body weight

Answer

10 mg/kg body weight

Answer

20 mg/kg body weight

Answer

15 mg/kg body weight

Question 7

What is the drug of choice for actinomycosis?

Accepted Answer

Penicillin

Answer

Sulfonamides

Answer

Tetracycline

Answer

Azithromycin

Question 8

What is the antibiotic of choice in patients with penicillin sensitivity?

Accepted Answer

Erythromycin

Answer

Streptomycin

Answer

Tetracycline

Answer

Chloramphenicol

Question 9

What is the drug of choice for prophylaxis of meningococcal meningitis in a pregnant female after contact with a case?

Accepted Answer

Ceftriaxone

Answer

Ciprofloxacin

Answer

Cefalexin

Answer

Rifabutin

Question 10

What is the recommended daily dose of Isoniazid for children?

Accepted Answer

10-20 mg/kg

Answer

5 mg/kg

Answer

15-25 mg/kg

Answer

20-40 mg/kg

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?